Local endothelial complement activation reverses endothelial quiescence, enabling t-cell homing, and tumor control during t-cell immunotherapy

Cancer immunotherapy relies upon the ability of T cells to infiltrate tumors. The endothelium constitutes a barrier between the tumor and effector T cells, and the ability to manipulate local vascular permeability could be translated into effective immunotherapy. Here, we show that in the context of...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Andrea Facciabene, Francesco De Sanctis, Stefano Pierini, Edimara S. Reis, Klara Balint, John Facciponte, Jens Rueter, Masahiro Kagabu, Paola Magotti, Evripidis Lanitis, Robert A. DeAngelis, Ronald J. Buckanovich, Wenchao C. Song, John D. Lambris, George Coukos
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Taylor & Francis Group 2017-09-01
Edice:	OncoImmunology
Témata:	cancer complement c5a endothelium immunotherapy
On-line přístup:	http://dx.doi.org/10.1080/2162402X.2017.1326442
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!